BioSpace News Archive

One in 10 people suffer from the debilitating effects of Plantar Fasciitis at least once in their lives.

Cerus Corporation (Nasdaq: CERS) today announced that Kevin D. Green, Cerus’ vice president, finance and chief financial officer, will present and provide a corporate update at the Baird 2018 Global Healthcare Conference in New York City on Thursday, September 6, 2018 at 8:30 a.m. ET.

Accreditation Council for Medical Affairs (ACMA), an independent, self-governing organization whose mission is to promote standards of excellence around technical competencies and ethical practices for pharmaceutical industry professionals in medical & scientific affairs, has appointed two power players to its Board of Governors.

According to the data compiled by Energias Market Research, the global medical cannabis market is expected to increase from USD 8.28 Billion in 2017 to USD 28.97 Billion in 2024 while at a CAGR of 19.1% from 2018 to 2024.

Shareholder rights law firm Johnson Fistel, LLP has launched an investigation into whether the board members of K2M Group Holdings, Inc.

This appointment will further drive current and future development of Citoxlab’s European sites, which are already experiencing strong growth.

Today, Stand Up To Cancer (SU2C), a division of the Entertainment Industry Foundation, announced “It’s #Up2Us: Stand Up To Cancer | The Digital Live Show,” a one-hour standalone digital event that will stream on Facebook, Twitter, and YouTube from the Barker Hangar in Santa Monica at 7:00 PM ET / 4:00 PM PT on Friday Sept. 7,

Universal Hospital Services, Inc. (“UHS”), a leading, nationwide provider of healthcare technology management and service solutions to the U.S. healthcare industry, and Federal Street Acquisition Corp. (NASDAQ: FSACU, FSAC, FSACW) (“FSAC”), a special purpose acquisition company sponsored by an affiliate of Thomas H. Lee Partners, L.P., today announced that UHS will participate in two upcoming healthcare conferences:

Shareholder rights law firm Johnson Fistel, LLP is investigating potential violations of the federal securities laws by Cronos Group Inc. (“Cronos”) (NASDAQ: CRON).

Scientific Intake, a company dedicated to developing innovative technology for weight management, announced today that William Longley, Founder and Chairman of the Board has resigned from the Board and as an officer of the Company.